4.6 Article

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 298, 期 5, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.jbc.2022.101848

关键词

-

资金

  1. Innovation Foundation Denmark [5188-00003B]
  2. BMBF (the German Federal Ministry of Education and Research)
  3. Lundbeck Foundation [R276-2018-671]
  4. Novo Nordisk Foundation [NNFSA170028392, NNF17OC0028806]
  5. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC 2067/1-390729940]

向作者/读者索取更多资源

This study reveals the inhibitory effect of glycation on alpha-synuclein fibril formation and provides insights into its molecular mechanism. Glycation primarily affects the elongation of alpha-synuclein and has a modest impact on oligomerization.
Glycation is a nonenzymatic posttranslational modification (PTM) known to be increased in the brains of hyperglycemic patients. Alpha-synuclein (alpha SN), a central player in the etiology of Parkinson's disease, can be glycated at lysine residues, thereby reducing alpha SN fibril formation in vitro and modulating alpha SN aggregation in cells. However, the molecular basis for these effects is unclear. To elucidate this, we investigated the aggregation of alpha SN modified by eight glycating agents, namely the dicarbonyl compound methylglyoxal (MGO) and the sugars ribose, fructose, mannose, glucose, galactose, sucrose, and lactose. We found that MGO and ribose modify alpha SN to the greatest extent, and these glycation products are the most efficient inhibitors of fibril formation. We show glycation primarily inhibits elongation rather than nucleation of alpha SN and has only a modest effect on the level of oligomerization. Furthermore, glycated alpha SN is not significantly incorporated into fibrils. For both MGO and ribose, we discovered that a level of similar to 5 modifications per alpha SN is optimal for inhibition of elongation. The remaining sugars showed a weak but optimal inhibition at similar to 2 modifications per alpha SN. We propose that this optimal level balances the affinity for the growing ends of the fibril (which decreases with the extent of modification) with the ability to block incorporation of subsequent alpha SN subunits (which increases with modification). Our results are not only relevant for other alpha SN PTMs but also for understanding PTMs affecting other fibrillogenic proteins and may thus open novel avenues for therapeutic intervention in protein aggregation disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

A Protein Corona Modulates Interactions of α-Synuclein with Nanoparticles and Alters the Rates of the Microscopic Steps of Amyloid Formation

Hossein Mohammad-Beigi, Masumeh Zanganeh, Carsten Scavenius, Hoda Eskandari, Azad Farzadfard, Seyed Abbas Shojaosadati, Jan J. Enghild, Daniel E. Otzen, Alexander K. Buell, Duncan S. Sutherland

Summary: Nanoparticles can modulate protein aggregation and fibril formation in amyloid diseases. By attaching a protein corona to the nanoparticles, the interactions between alpha-Synuclein and the nanoparticles were studied. The results showed that the nanoparticles surface promotes the primary nucleation step of fibril formation and that the protein corona reduces the accelerating effect of the nanoparticles.

ACS NANO (2022)

Article Immunology

Solution Structure of the Cutibacterium acnes-Specific Protein RoxP and Insights Into Its Antioxidant Activity

Kristian Stodkilde, Jakob Toudahl Nielsen, Steen Vang Petersen, Bernhard Paetzold, Holger Bruggemann, Frans A. A. Mulder, Christian Brix Folsted Andersen

Summary: Cutibacterium acnes is a bacterium commonly found on human skin, and its secreted protein RoxP has been shown to have antioxidant activity and can alleviate cell damage caused by radicals. The structure of RoxP reveals a positively charged groove that may function as a binding site for cofactors or substrates. It is not responsible for the adhesion of C. acnes bacteria to human keratinocytes, but the antioxidant activity of RoxP is likely attributed to tyrosine-containing stretches located in its flexible loop.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Multidisciplinary Sciences

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Jasmin Bartl, Marco Zanini, Flavia Bernardi, Antoine Forget, Lena Bluemel, Julie Talbot, Daniel Picard, Nan Qin, Gabriele Cancila, Qingsong Gao, Soumav Nath, Idriss Mahoungou Koumba, Marietta Wolter, Francois Kuonen, Maike Langini, Thomas Beez, Christopher Munoz, David Pauck, Viktoria Marquardt, Hua Yu, Judith Souphron, Mascha Korsch, Christina Moelders, Daniel Berger, Sarah Goebbels, Frauke-Dorothee Meyer, Bjorn Scheffler, Barak Rotblat, Sven Diederichs, Vijay Ramaswamy, Hiromishi Suzuki, Anthony Oro, Kai Stuehler, Anja Stefanski, Ute Fischer, Gabriel Leprivier, Dieter Willbold, Gerhard Steger, Alexander Buell, Marcel Kool, Peter Lichter, Stefan M. Pfister, Paul A. Northcott, Michael D. Taylor, Arndt Borkhardt, Guido Reifenberger, Olivier Ayrault, Marc Remke

Summary: Long non-coding RNA (lncRNA) HHIP-AS1 stabilizes the mRNA of dynein complex 1, thereby promoting the pro-mitotic effects of SHH-driven tumors.

NATURE COMMUNICATIONS (2022)

Article Immunology

Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity

Henrik Pedersen, Rasmus Kjeldsen Jensen, Annette Gudmann Hansen, Steen Vang Petersen, Steffen Thiel, Nick Stub Laursen, Gregers Rom Andersen

Summary: The complement system plays a role in labeling pathogens and dying host cells for clearance. A nanobody has been discovered that specifically binds to degradation products of complement component C3 and effectively inhibits complement deposition. This nanobody could be a potential candidate for studying complement-related diseases in rodent models.

FRONTIERS IN IMMUNOLOGY (2022)

Article Chemistry, Multidisciplinary

Superanionic Solvent-Free Liquid Enzymes Exhibit Enhanced Structures and Activities

Ye Zhou, Jannik Nedergaard Pedersen, Jacob Nedergaard Pedersen, Nykola C. Jones, Soren Vronning Hoffmann, Steen Vang Petersen, Jan Skov Pedersen, Adam Perriman, Renjun Gao, Zheng Guo

Summary: This study focuses on the anionization of a carboxylate-enriched mutant of Bacillus subtilis lipase A (8M) to produce biofluids with enhanced hydrolytic activity. The resulting biofluids show a 2.5-fold increase in activity compared to those based on anionic polymer surfactants. Additionally, the use of anion-type biofluids with Myoglobin (Mb) is evaluated, revealing partial recovery of the active alpha-helix level in the biofluids. These highly active solvent-free liquid enzymes exhibit increased thermal stability and open up new possibilities in solvent-free liquid protein research.

ADVANCED SCIENCE (2022)

Article Biology

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains

Rebecca Sternke-Hoffmann, Thomas Pauly, Rasmus K. Norrild, Jan Hansen, Florian Tucholski, Magnus Haraldson Hoie, Paolo Marcatili, Mathieu Dupre, Magalie Duchateau, Martial Rey, Christian Malosse, Sabine Metzger, Amelie Boquoi, Florian Platten, Stefan U. Egelhaaf, Julia Chamot-Rooke, Roland Fenk, Luitgard Nagel-Steger, Rainer Haas, Alexander K. Buell

Summary: Researchers introduce a new systematic workflow for the biophysical characterization of multiple myeloma patient-derived immunoglobulin light chains (IgLCs) and find that in vivo aggregation behavior is unlikely to be linked to any single biophysical or biochemical parameter. They also discover that the potential to form amyloid fibrils is widespread in IgLC sequences and not limited to those sequences that form fibrils in patients.

BMC BIOLOGY (2023)

Article Medicine, Research & Experimental

Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats

Andreas V. Madsen, Peter Kristensen, Alexander K. Buell, Steffen Goletz

Summary: This study demonstrates a simple and efficient method to generate high-quality bsAbs with both binding functionalities intact by fusing sdAbs onto IgG scaffolds through flexible linkers. By systematically comparing sdAb fusion strategies, the results show that fusion of sdAbs to the heavy chain promotes good expression, stability, and efficient binding to both antigens. The study also provides a toolbox of complementary methods for in-depth analysis of key features, such as dual antigen binding and stability, to ensure high bsAb quality.
Article Chemistry, Multidisciplinary

Mass photometric detection and quantification of nanoscale a-synuclein phase separation

Soumik Ray, Thomas O. Mason, Lars Boyens-Thiele, Azad Farzadfard, Jacob Aunstrup Larsen, Rasmus K. Norrild, Nadin Jahnke, Alexander K. Buell

Summary: Using mass photometry, it is shown that the Parkinson's disease-related protein, α-synuclein, can form dynamic nanoscale clusters and promote amyloid fibril formation. The formation of these nanoclusters is instantaneous and occurs at much wider ranges of solution conditions. Mass photometry is demonstrated to be a promising methodology for detecting and quantifying nanoscale precursors of phase separation.

NATURE CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR

Jayakrishna Shenoy, Alons Lends, Melanie Berbon, Muhammed Bilal, Nadia El Mammeri, Mathilde Bertoni, Ahmad Saad, Estelle Morvan, Axelle Grelard, Sophie Lecomte, Francois-Xavier Theillet, Alexander K. Buell, Brice Kauffmann, Birgit Habenstein, Antoine Loquet

Summary: Aberrant aggregation of TDP-43 protein is linked to lethal neurodegenerative diseases. Using a combination of techniques, we found that different fragments of TDP-43 adopt distinct polymorphic structures in their amyloid fibrillar state. Our study reveals that removal of a small portion of the low-complexity sequence can lead to amyloid fibrils with similar macroscopic features but different local structural arrangements.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Biochemistry & Molecular Biology

Periostin C-Terminal Is Intrinsically Disordered and Interacts with 143 Proteins in an In Vitro Epidermal Model of Atopic Dermatitis

Christian E. Rusbjerg-Weberskov, Mette Liere Johansen, Jan S. Nowak, Daniel E. Otzen, Jan Skov Pedersen, Jan J. Enghild, Nadia Sukusu Nielsen

Summary: Human periostin is a matricellular protein that plays important roles in extracellular matrix remodeling, tumor development, and inflammatory diseases. The C-terminal domain of periostin interacts with other domains and proteins, potentially contributing to the pathogenesis of diseases such as atopic dermatitis.

BIOCHEMISTRY (2023)

Review Chemistry, Physical

Proteins and biosurfactants: Structures, functions, and recent applications

Marcos Lopez Hernandez, Jan Skov Pedersen, Daniel E. Otzen

Summary: The synergies between surfactants and proteins are widely utilized in various fields, but there is still room for improvement in terms of sustainability. Biosurfactants offer an attractive alternative, and understanding their interactions with proteins can open up new opportunities. This review focuses on the self-assembly of protein:BS complexes and the effects of BS on enzymatic activity.

CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2023)

Article Multidisciplinary Sciences

Elevated concentrations cause upright alpha-synuclein conformation at lipid interfaces

Steven J. Roeters, Kris Strunge, Kasper B. Pedersen, Thaddeus W. Golbek, Mikkel Bregnhoj, Yuge Zhang, Yin Wang, Mingdong Dong, Janni Nielsen, Daniel E. Otzen, Birgit Schiott, Tobias Weidner

Summary: This study reports a mechanism explaining why lipid membranes catalyze the formation of harmful aggregates at elevated concentrations.

NATURE COMMUNICATIONS (2023)

Article Chemistry, Physical

Pyroglutamate-modified amyloid β(3-42) monomer has more β-sheet content than the amyloid β(1-42) monomer

Soumav Nath, Alexander K. Buell, Bogdan Barz

Summary: The aggregation of amyloid beta (Aβ) peptide is a major hallmark of Alzheimer's disease. Different forms of Aβ peptide in amyloid plaques have distinct biophysical and biochemical properties, with N-terminally pyroglutamate-modified variant pE-Aβ(3-42) being a significant fraction in AD brains. Molecular dynamics simulations reveal significant differences in the structural flexibility, secondary structure, and hydrophobic exposure between pE-Aβ(3-42) monomer and Aβ(1-42) monomer, which might contribute to their different behavior in biophysical experiments.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2023)

暂无数据